Diabetes News

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

Tirzepatide significantly reduced HF outcomes and symptoms for patients with HF and preserved ejection fraction and obesity, according to the top-line results of the phase 3 SUMMIT clinical trial.

New prescriptions of GLP-1 receptor agonists for the treatment of obesity have increased significantly among individuals without type 2 diabetes in the last decade, according to a study in Annals of Internal Medicine.

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

Reductions in unprocessed red meat and processed meat consumption by 30% over a decade led to substantial reductions in chronic diseases and mortality among adults in the United States, a microsimulation study showed.

For the 30th straight year, Cleveland Clinic topped U.S. News & World Report’s Best Hospitals rankings for cardiology and heart surgery.

People who delayed diabetes through diet and exercise for at least 4 years after their prediabetes diagnosis had a lower risk for death and other adverse outcomes vs. those who were diagnosed with diabetes during that time, a study showed.

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology.

Adults with obstructive sleep apnea had elevated odds of developing various heart-related health conditions compared with those without it, and the association was strongest in younger individuals, researchers reported.

CHICAGO — A greater intake of ultraprocessed foods, or UPFs, did not significantly increase the risk for type 2 diabetes in middle-aged adults, according to a study presented at NUTRITION.